Jeremy Bender, CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. (DAWN), sold 15,746 shares at $16.08 ($253K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Open-market sale of $253k DAWN by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.08 | 7,873 | $127K | 50.0% |
| 2 | $16.08 | 7,873 | $127K | 50.0% |
| Total | $16.08 avg | 15,746 | $253K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |